Literature DB >> 27354486

Cellular Profiles and Molecular Mediators of Lesion Cascades in the Placode in Human Open Spinal Neural Tube Defects.

Bea Kowitzke1, Gesa Cohrs1, Ivo Leuschner1, Arend Koch1, Michael Synowitz1, Hubertus Maximilian Mehdorn1, Janka Held-Feindt1, Friederike Knerlich-Lukoschus2.   

Abstract

Myelomeningoceles (mmc) are clinically challenging CNS malformations. Although improvement in their management has been achieved with respect to antenatal diagnosis, prevention, and fetal surgery, the cellular mechanisms of damage in the neural placode are poorly understood. We aimed to identify cellular and molecular factors in lesion amplifying cascades in mmc placodes. Seventeen mmc specimens obtained during reconstructive surgery that harbored sufficient neuroepithelial tissue were investigated. Normal adult and stillborn spinal cord tissue served as controls. Placodes exhibited similar cellular profiles with consistent neuronal marker expression, elevated GFAP-/vimentin immunoreactivity in all, and CD3/CD11b/CD68-immunolabeling in some cases. Increased expression of pro-inflammatory (tumor necrosis factor, interleukin-1β [Il-1β]/IL-1 receptor type 1 [IL-R1]) and neuroprotective erythropoietin/erythropoietin receptor (Epo/EpoR) cytokines was detected by immunohistochemistry, double-fluorescence labeling, and real-time RT-PCR. In all cases, there was a multi-cellular induction of IL-1β and IL1-R1. EpoR and Epo immunoreactivity was elevated in some cases with neuronal expression patterns. Epo was further co-expressed with HIF-1/-2α, which paralleled Epo induction in the corresponding placodes. These observations confirm the induction of cellular and molecular alterations in human mmc placodes that resemble the secondary lesion cascades induced by spinal cord injury. The pro-inflammatory and neuroprotective cytokine expression in mmc placodes may represent new targets for the treatment of open neural tube defects.
© 2016 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Cytokines; Erythropoietin; Immunohistochemistry; Inflammation; Myelomeningocele; Real-time RT-PCR.

Mesh:

Substances:

Year:  2016        PMID: 27354486     DOI: 10.1093/jnen/nlw057

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  5 in total

1.  Expression profiles of pro-inflammatory and pro-apoptotic mediators in secondary tethered cord syndrome after myelomeningocele repair surgery.

Authors:  Gesa Cohrs; Bea Drucks; Jan-Philip Sürie; Christian Vokuhl; Michael Synowitz; Janka Held-Feindt; Friederike Knerlich-Lukoschus
Journal:  Childs Nerv Syst       Date:  2018-10-03       Impact factor: 1.475

2.  Amniotic fluid transcriptomics reflects novel disease mechanisms in fetuses with myelomeningocele.

Authors:  Tomo Tarui; Aimee Kim; Alan Flake; Lauren McClain; John D Stratigis; Inbar Fried; Rebecca Newman; Donna K Slonim; Diana W Bianchi
Journal:  Am J Obstet Gynecol       Date:  2017-07-20       Impact factor: 10.693

Review 3.  Spinal Cord Injury in Myelomeningocele: Prospects for Therapy.

Authors:  Karolina Janik; Meredith A Manire; George M Smith; Barbara Krynska
Journal:  Front Cell Neurosci       Date:  2020-06-30       Impact factor: 5.505

4.  Perspective on inflammatory cytokines in open spinal dysraphism.

Authors:  Friederike Knerlich-Lukoschus
Journal:  Neural Regen Res       Date:  2023-02       Impact factor: 6.058

5.  Early neonatal loss of inhibitory synaptic input to the spinal motor neurons confers spina bifida-like leg dysfunction in a chicken model.

Authors:  Md Sakirul Islam Khan; Hiroaki Nabeka; Farzana Islam; Tetsuya Shimokawa; Shouichiro Saito; Xuan Li; Soichiro Kawabe; Fumihiko Hamada; Tetsuya Tachibana; Seiji Matsuda
Journal:  Dis Model Mech       Date:  2017-12-19       Impact factor: 5.758

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.